Challenges and opportunities in the use of CTCs for companion diagnostic development

Elizabeth A Punnoose1, Mark R Lackner

  • 1Department of Oncology Biomarker Development, Genentech, Inc, South San Francisco, CA, USA. punnoose.elizabeth@gene.com